Skip to main contentAI and Advanced
/
INDRAMEDCO · NSEBSE SENSEX74,314.59-0.03%BSE |
NIFTY 5023,270.6+0.23%NSE |
NIFTY BANK56,055.75-0.42%NSE |
NIFTY IT29,155.6+0.23%NSE |
NIFTY AUTO27,159.15+0.99%NSE |
NIFTY FMCG45,572.7+0.03%NSE |
NIFTY PHARMA26,579.25+1.66%NSE |
NIFTY 50022,654.65+0.54%NSE |
IN
NSE · Equity shares · Healthcare Facilities7.10 · 1.99%
Indraprastha Medical Corporation INDRAMEDCO
NSE:INR 363.65
BSE:INR 363.2
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections9 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for INDRAMEDCO
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 356.55
Day rangeINR 356 — INR 367.6
52-week rangeINR 342 — INR 640.85
Volume1.61 L
Market cap3,331.92
P/E18.59
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)1,482.51
Net Income (INR Cr)183.62
Rev Growth (5 Year %)19.3
EPS Growth (5 Year %)139.52
P/E Ratio18.59
Book Value80.72
EPS20.03
Price/BV4.51Computed
Research path: Interpret Indraprastha Medical Corporation's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
INDRAMEDCOIndraprastha Medical Corporation1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 991.36 | 851.62 | 723.24 |
| Cash Equivalents | 258.37 | Not available | Not available |
| Other Liabilities Total | 27.89 | 30.3 | 28.07 |
| Common Stock Total | 91.67 | 91.67 | 91.67 |
| Other Current Assets Total | 12.28 | 3.16 | 2.58 |
| Total Assets | 991.36 | 851.62 | 723.24 |
| Current Portof LT Debt/Capital Leases | 3.68 | 2.22 | 1.68 |
| Cash | 4.93 | 61.48 | 61.6 |
| Total Equity | 740.37 | 596.68 | 477.76 |
| Long Term Investments | 203.5 | 54.92 | 60.52 |
| Retained Earnings(Accumulated Deficit) | 648.7 | 518.01 | 398.27 |
| Total Common Shares Outstanding | 9.17 | 9.17 | 9.17 |
| Tangible Book Valueper Share Common Eq | 80.72 | 65.02 | 52 |
| Total Liabilities | 250.99 | 254.94 | 245.48 |
| Total Debt | 36.86 | 32.76 | 33.95 |
| Short Term Investments | 10.92 | 257.11 | 160.25 |
| Cashand Short Term Investments | 274.22 | 318.59 | 221.85 |
| Total Receivables Net | 122.23 | 85.79 | 64.87 |
| Deferred Income Tax | 20.37 | 15.39 | 19.72 |
| Accounts Receivable-Trade Net | 112.16 | 75.45 | 58.4 |
| Property/Plant/Equipment Total-Net | 367.27 | 359.99 | 346.36 |
| Total Current Liabilities | 169.55 | 178.71 | 165.42 |
| Total Inventory | 7.86 | 6.99 | 7.53 |
| Accounts Payable | 128.15 | 122.54 | 139.6 |
| Other Currentliabilities Total | 37.72 | 53.95 | 24.14 |
| Total Long Term Debt | 33.18 | 30.54 | 32.27 |
| Intangibles Net | 0.34 | 0.59 | 1.05 |
| Other Long Term Assets Total | 3.66 | 2.72 | 3.21 |
| Total Current Assets | 416.59 | 431.13 | 307.98 |
| Capital Lease Obligations | 33.18 | 30.54 | 32.27 |
| Accumulated Depreciation Total | Not available | -227.53 | -212.84 |
| Other Equity Total | Not available | -13 | -12.18 |
| Prepaid Expenses | Not available | 16.6 | 11.15 |
| Property/Plant/Equipment Total-Gross | Not available | 555 | 558.73 |
| Notes Payable/Short Term Debt | Not available | 0 | 0 |
| Note Receivable-Long Term | Not available | 2.27 | 4.12 |
Fundamentals
Valuation and ratios
Valuation
PEG Ratio0.64
Price to Sale Ratio2.25
Growth
Debt 5Yr CAGR %71.1
Margins
Operating Margin 12m15.06
Operating Margin 5y Avg12.78
Net Profit Margin 12m12.39
Net Profit Margin 5y10.1
Yield
Dividend Yield %1.09
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskBalanced risk
Board Risk37.94
Analyst consensus
ConsensusStrong Buy
Consensus score1.00
Analyst opinions1
Strong Sell count0
Sell count0
Hold count0
Buy count0
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Apollo Hospitals Enterprise | INR 8,812.9 | 1.27 L | 64.93 | — |
| Max Healthcare Institute | INR 1,075 | 1.05 L | 71.47 | — |
| Fortis Healthcare | INR 935 | 70,588.59 | 67.89 | — |
| Aster DM Healthcare | INR 844.4 | 44,157.18 | 102.55 | — |
| Narayana Hrudayalaya | INR 1,881 | 38,187.34 | 48.07 | — |
Shareholding
Ownership
- Promoter
- 51.00%
- FII
- 2.77%
- MF
- 0.01%
- Other
- 46.22%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Indraprastha Medical Corporation Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift - Markets MojoMarket news · 4 Jun 2026, 8:21 am
Indraprastha Medical Corporation Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift Markets Mojo
Indraprastha Medical Corporation Ltd: Valuation Shift Enhances Price Attractiveness Amid Sector Comparisons - Markets MojoMarket news · 4 Jun 2026, 8:09 am
Indraprastha Medical Corporation Ltd: Valuation Shift Enhances Price Attractiveness Amid Sector Comparisons Markets Mojo
Indraprastha Medical Corporation Ltd Surges 7.13% to Day'... - Markets MojoMarket news · 3 Jun 2026, 3:08 pm
Indraprastha Medical Corporation Ltd Surges 7.13% to Day'... Markets Mojo
Indraprastha Medical Corporation Ltd is Rated Sell - Markets MojoMarket news · 3 Jun 2026, 10:36 am
Indraprastha Medical Corporation Ltd is Rated Sell Markets Mojo
Indraprastha Medical Corporation schedules investor meetings in Mumbai - scanx.tradeMarket news · 3 Jun 2026, 5:22 am
Indraprastha Medical Corporation schedules investor meetings in Mumbai scanx.trade
Indraprastha Medical Corporation Ltd: Valuation Shifts Signal Renewed Price Attractiveness - Markets MojoMarket news · 29 May 2026, 8:28 am
Indraprastha Medical Corporation Ltd: Valuation Shifts Signal Renewed Price Attractiveness Markets Mojo
Corporate actions
Events
- board MeetingsQuarterly Results
- dividendRs.4.0000 per share(40%)Final Dividend
- board MeetingsAudited Results & Final Dividend
- annual General MeetingPOM
- board MeetingsQuarterly Results
- board MeetingsQuarterly Results
- annual General MeetingAGM
- dividendRs.4.5000 per share(45%)Final Dividend
Rusaka Markets Community
Discussion and sentiment for Indraprastha Medical Corporation
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Indraprastha Medical Corporation Limited is an India-based company engaged in the healthcare business. The business activities of the Company are running and operating hospitals, which include Indraprastha Apollo Hospitals and Apollo Hospitals. Indraprastha Apollo Hospitals is a multi-specialty tertiary acute care hospital with approximately 710 beds and is spread over 15 acres and has a built-up area of over 600,000 square feet. It has approximately 52 specialties under one roof with the major specialties being anesthesia, cardiology, cardiac surgery, cancer, pediatrics, critical care, emergency care, fetal medicine, gastroenterology and hepatology, obstetrics & gynecology, interventional radiology, IVF, liver and kidney transplant, nuclear medicine, nephrology, neurosciences, ophthalmology, orthopedics, otolaryngology (ENT), pediatrics, pediatric surgery, psychiatry and clinical psychology, rheumatology, spine surgery, urology and andrology and vascular and endovascular surgery.
Company facts
- Industry
- Healthcare Facilities
- Sector
- Healthcare Facilities
- NSE Code
- INDRAMEDCO
- BSE Code
- 532150
Questions
Stock FAQ
What is the symbol and ISIN of Indraprastha Medical Corporation?
Indraprastha Medical Corporation has the symbol INDRAMEDCO and ISIN - INE681B01017.
What is the current price of Indraprastha Medical Corporation?
Indraprastha Medical Corporation is currently trading at INR 363.65.
What are the year high and year low of Indraprastha Medical Corporation?
Indraprastha Medical Corporation has a year high of INR 640.85 and a year low of INR 342.00.
What is the market capitalization of Indraprastha Medical Corporation?
Indraprastha Medical Corporation has a market capitalization of INR 3,331.92 crore.
What is the P/E ratio of Indraprastha Medical Corporation?
Indraprastha Medical Corporation has a P/E ratio of 18.59.
What is the dividend yield of Indraprastha Medical Corporation?
Indraprastha Medical Corporation has a dividend yield of 1.09%.
How is the financial performance of Indraprastha Medical Corporation based on revenue, net income, and EPS?
Indraprastha Medical Corporation has revenue of INR 1,482.51 crore, net income of INR 183.62 crore, and EPS of INR 20.03.
What is the book value of Indraprastha Medical Corporation?
Indraprastha Medical Corporation has a book value of INR 80.72.
What is the debt-to-equity ratio of Indraprastha Medical Corporation?
Indraprastha Medical Corporation has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Indraprastha Medical Corporation?
Indraprastha Medical Corporation has a price-to-book ratio of 4.51 and a price-to-sales ratio of 2.25.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.